TAK
Takeda Pharmaceutical Co Ltd
17.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures per share in JPY.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,130.37 | 1,146.57 | 1,101.97 | 1,125.28 | 1,084.51 | 1,050.69 | 1,016.12 | 1,131.46 | 1,282.74 | 1,349.00 | 1,426.96 | 1,490.36 | |
| 331.25 | 339.65 | 355.49 | 315.19 | 341.14 | 347.90 | 315.95 | 350.90 | 396.23 | 452.91 | 492.17 | 729.39 | |
| 799.12 | 806.92 | 746.48 | 810.09 | 743.37 | 702.79 | 700.18 | 780.56 | 886.51 | 896.09 | 934.79 | 760.97 | |
| 242.94 | 219.45 | 198.69 | 206.84 | 190.45 | 157.19 | 144.84 | 166.78 | 201.71 | 230.94 | 227.43 | 223.58 | |
| 317.53 | 412.84 | 393.86 | 399.20 | 371.08 | 307.99 | 278.25 | 281.00 | 317.64 | 333.41 | 344.09 | 338.23 | |
| 881.30 | 723.92 | 647.31 | 656.42 | 660.45 | 670.74 | 538.35 | 634.46 | 730.28 | 828.36 | 828.09 | 582.20 | |
| -82.18 | 82.99 | 99.17 | 153.67 | 105.99 | 32.05 | 161.82 | 146.10 | 156.22 | 67.73 | 106.70 | 178.76 | |
| 20.90 | 20.26 | 14.79 | 20.29 | 24.90 | 0.47 | 41.56 | 38.81 | 37.26 | 0.34 | 42.77 | 118.27 | |
| -92.47 | 76.47 | 91.20 | 138.05 | 49.07 | -19.40 | 116.37 | 95.92 | 119.47 | 16.70 | 54.53 | 86.06 | |
| -1.53 | 23.51 | 17.71 | 19.38 | -7.30 | -33.53 | -3.16 | 22.95 | 18.49 | -28.92 | 20.85 | 22.55 | |
| -92.69 | 50.86 | 73.13 | 118.78 | 56.43 | 14.12 | 119.48 | 72.93 | 100.97 | 45.58 | 33.61 | 63.43 | |
| 36.42 | 221.94 | 188.88 | 228.77 | 240.05 | 214.50 | 312.58 | 375.11 | 408.97 | 361.93 | 377.02 | 442.87 |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.